Cargando…

Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa

BACKGROUND: Shwaskas Chintamani Rasa (SKC) and Kas Shwas Hari Rasa (KSH) are the Ayurvedic herbo-mineral formulations. These Ayurvedic formulations contain heavy metals which is the reason of concern and might bring up the safety issue. OBJECTIVE: This research article is aimed to study chronic toxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Waghmare, Chaitali S., Bidve, Shivcharan, Gudi, R.V., Yadav, Santosh, Chawda, Mukesh B., Nalawade, Megha L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471453/
https://www.ncbi.nlm.nih.gov/pubmed/36088824
http://dx.doi.org/10.1016/j.jaim.2022.100615
_version_ 1784789078905978880
author Waghmare, Chaitali S.
Bidve, Shivcharan
Gudi, R.V.
Yadav, Santosh
Chawda, Mukesh B.
Nalawade, Megha L.
author_facet Waghmare, Chaitali S.
Bidve, Shivcharan
Gudi, R.V.
Yadav, Santosh
Chawda, Mukesh B.
Nalawade, Megha L.
author_sort Waghmare, Chaitali S.
collection PubMed
description BACKGROUND: Shwaskas Chintamani Rasa (SKC) and Kas Shwas Hari Rasa (KSH) are the Ayurvedic herbo-mineral formulations. These Ayurvedic formulations contain heavy metals which is the reason of concern and might bring up the safety issue. OBJECTIVE: This research article is aimed to study chronic toxicity of SKC and KSH for safety aspect in Wistar rats. MATERIAL AND METHOD: A study group of 220 healthy rats were divided into six groups. These rats were administered with SKC and KSH formulations where both the formulations were administered for 180 consecutive days. SKC was administered at doses of 58 mg/kg (equivalent to therapeutic dose i.e. TD), 145 mg/kg (2.5 TD), 290 mg/kg (5 TD) and KSH was administered at dose of 58 mg/kg (TD). According to OECD guideline 452, the effect of these formulations was examined on hematology, serum biochemistry and histopathology of various organs. RESULTS: Both the formulations did not produce any signs or symptoms of treatment related toxicity in both male and female Wistar rats at therapeutic dose (TD), 2.5 times TD and 5 times TD. CONCLUSION: Based on these findings, the NOAEL (No observed adverse effect level) for test formulations SKC and KSH tablets in male and female wistar rats concluded to be preclinically safe.
format Online
Article
Text
id pubmed-9471453
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94714532022-09-15 Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa Waghmare, Chaitali S. Bidve, Shivcharan Gudi, R.V. Yadav, Santosh Chawda, Mukesh B. Nalawade, Megha L. J Ayurveda Integr Med Original Research Article BACKGROUND: Shwaskas Chintamani Rasa (SKC) and Kas Shwas Hari Rasa (KSH) are the Ayurvedic herbo-mineral formulations. These Ayurvedic formulations contain heavy metals which is the reason of concern and might bring up the safety issue. OBJECTIVE: This research article is aimed to study chronic toxicity of SKC and KSH for safety aspect in Wistar rats. MATERIAL AND METHOD: A study group of 220 healthy rats were divided into six groups. These rats were administered with SKC and KSH formulations where both the formulations were administered for 180 consecutive days. SKC was administered at doses of 58 mg/kg (equivalent to therapeutic dose i.e. TD), 145 mg/kg (2.5 TD), 290 mg/kg (5 TD) and KSH was administered at dose of 58 mg/kg (TD). According to OECD guideline 452, the effect of these formulations was examined on hematology, serum biochemistry and histopathology of various organs. RESULTS: Both the formulations did not produce any signs or symptoms of treatment related toxicity in both male and female Wistar rats at therapeutic dose (TD), 2.5 times TD and 5 times TD. CONCLUSION: Based on these findings, the NOAEL (No observed adverse effect level) for test formulations SKC and KSH tablets in male and female wistar rats concluded to be preclinically safe. Elsevier 2022 2022-09-08 /pmc/articles/PMC9471453/ /pubmed/36088824 http://dx.doi.org/10.1016/j.jaim.2022.100615 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Waghmare, Chaitali S.
Bidve, Shivcharan
Gudi, R.V.
Yadav, Santosh
Chawda, Mukesh B.
Nalawade, Megha L.
Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa
title Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa
title_full Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa
title_fullStr Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa
title_full_unstemmed Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa
title_short Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa
title_sort evaluation of chronic toxicological profile of herbo-mineral formulations: shwaskas chintamani rasa and its marketed formulation namely kas shwas hari rasa
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471453/
https://www.ncbi.nlm.nih.gov/pubmed/36088824
http://dx.doi.org/10.1016/j.jaim.2022.100615
work_keys_str_mv AT waghmarechaitalis evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa
AT bidveshivcharan evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa
AT gudirv evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa
AT yadavsantosh evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa
AT chawdamukeshb evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa
AT nalawademeghal evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa